Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey.
Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey.
J Fr Ophtalmol. 2021 Apr;44(4):485-493. doi: 10.1016/j.jfo.2020.09.027. Epub 2021 Feb 26.
Our goal is early detection of neuropathy in patients with type 2 diabetes with or without microalbuminuria in the absence of diabetic retinopathy and peripheral neuropathy by using in vivo corneal confocal microscopy (IVCCM).
A total of 60 type-2 diabetic patients, assigned to either a diabetes mellitus (DM) with microalbuminuria group (DM/MA+, n=30) or a DM without microalbuminuria group (DM/MA-, n=30), and 30 age-matched control subjects were enrolled in this study. All cases underwent evaluation of blood glucose level, HbA, lipid fractions, body mass index (BMI), and corneal sensitivity (CS). Corneal nerve fiber length (NFL), nerve fiber density (NFD), nerve branch density (NBD), and tortuosity coefficient (TC) were quantified by IVCCM. None of the patients had peripheral neuropathy or retinopathy.
Compared with the healthy subjects, NFL and NFD were reduced in both diabetic groups (P<0.0001), while NBD was significantly reduced in the DM/MA+ group. Between the diabetic groups, NFL, NFD, and NBD were significantly higher in the DM/MA- group (all P's<0.001). CS was significantly lower in DM/MA+ compared with DM/MA- and controls (both P's<0.0001). NFD and NFL were inversely correlated with age, triglyceride level, and BMI.
These results indicate that significant damage to small nerves, quantified using IVCCM, can be detected in the absence of retinopathy, peripheral neuropathy or microalbuminuria in type 2 diabetic patients. The severity of corneal nerve involvement may further increase in the presence of nephropathy. This feature may also be valuable for early detection of microvascular complications of DM, allowing for the prevention of progression of life threatening microvascular complications.
我们的目标是通过活体角膜共聚焦显微镜(IVCCM),在没有糖尿病视网膜病变和周围神经病变的情况下,对伴有或不伴有微量白蛋白尿的 2 型糖尿病患者进行神经病变的早期检测。
共纳入 60 例 2 型糖尿病患者,分为糖尿病伴微量白蛋白尿组(DM/MA+,n=30)和糖尿病不伴微量白蛋白尿组(DM/MA-,n=30),并纳入 30 名年龄匹配的对照者。所有患者均进行血糖水平、HbA、血脂成分、体重指数(BMI)和角膜敏感度(CS)评估。通过 IVCCM 量化角膜神经纤维长度(NFL)、神经纤维密度(NFD)、神经分支密度(NBD)和扭曲系数(TC)。所有患者均无周围神经病变或视网膜病变。
与健康对照组相比,两组糖尿病患者的 NFL 和 NFD 均降低(P<0.0001),而 DM/MA+组的 NBD 显著降低。两组糖尿病患者之间,DM/MA-组的 NFL、NFD 和 NBD 均显著升高(均 P<0.001)。与 DM/MA-组和对照组相比,DM/MA+组的 CS 显著降低(均 P<0.0001)。NFD 和 NFL 与年龄、甘油三酯水平和 BMI 呈负相关。
这些结果表明,在没有视网膜病变、周围神经病变或微量白蛋白尿的情况下,使用 IVCCM 可检测到 2 型糖尿病患者的小神经显著损伤。在伴有肾病的情况下,角膜神经受累的严重程度可能进一步增加。这一特征可能对早期发现糖尿病的微血管并发症也有价值,从而可以预防危及生命的微血管并发症的进展。